Bank of America’s Applied Molecular Transport Inc. Common Stock AMTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-202
Closed -$31 8315
2023
Q3
$31 Sell
202
-25,488
-99% -$6.78K ﹤0.01% 7546
2023
Q2
$6.63K Buy
25,690
+1,676
+7% +$475 ﹤0.01% 6941
2023
Q1
$7.68K Sell
24,014
-9,454
-28% -$4.93K ﹤0.01% 6979
2022
Q4
$14.1K Sell
33,468
-35,219
-51% -$35.4K ﹤0.01% 6842
2022
Q3
$67K Sell
68,687
-34,239
-33% -$60.5K ﹤0.01% 6547
2022
Q2
$300K Buy
102,926
+14,039
+16% +$59K ﹤0.01% 5801
2022
Q1
$668K Sell
88,887
-28,106
-24% -$233K ﹤0.01% 5603
2021
Q4
$1.64M Buy
116,993
+107,803
+1,173% +$2.13M ﹤0.01% 4764
2021
Q3
$237K Sell
9,190
-3,299
-26% -$105K ﹤0.01% 6191
2021
Q2
$571K Buy
12,489
+3,484
+39% +$165K ﹤0.01% 5313
2021
Q1
$397K Sell
9,005
-61
-0.7% -$2.97K ﹤0.01% 5542
2020
Q4
$279K Buy
9,066
+1,116
+14% +$35.4K ﹤0.01% 5384
2020
Q3
$253K Buy
+7,950
New +$195K ﹤0.01% 5156

Other funds holding AMTI

Bank of America's AMTI Position: Q4 2023 in Review

Bank of America sold out of Applied Molecular Transport Inc. Common Stock (AMTI) in Q4 2023, closing a stake of 202 shares — an estimated $31 sold.

Bank of America first reported a position in AMTI in Q3 2020 and held it in 13 quarters. The position peaked at $1.64M in Q4 2021. 2 funds tracked by Wall St. Rank hold AMTI as of Q4 2023.

  • Bank of America reported no remaining Applied Molecular Transport Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Bank of America sold 202 Applied Molecular Transport Inc. Common Stock shares in Q4 2023, an estimated $31.
  • Bank of America first reported a position in Applied Molecular Transport Inc. Common Stock in Q3 2020 and held it in 13 quarters.
  • Bank of America's Applied Molecular Transport Inc. Common Stock position peaked at $1.64M in Q4 2021.
  • 2 funds tracked by Wall St. Rank held Applied Molecular Transport Inc. Common Stock as of Q4 2023.

Based on Bank of America's 13F filing for Q4 2023, filed 14 Feb 2024.